ERWINAZE
Total Payments
$94,340
Transactions
75
Doctors
68
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $42.40 | 2 | 2 |
| 2023 | $33.16 | 1 | 1 |
| 2021 | $77.03 | 1 | 1 |
| 2020 | $9,218 | 13 | 12 |
| 2019 | $84,969 | 58 | 53 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $75,000 | 1 | 79.5% |
| Consulting Fee | $12,113 | 7 | 12.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 3.7% |
| Food and Beverage | $2,656 | 63 | 2.8% |
| Travel and Lodging | $1,071 | 3 | 1.1% |
Top Doctors Receiving Payments for ERWINAZE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Houston, TX | $75,000 | 1 |
| , MD | Pediatric Hematology-Oncology | Houston, TX | $9,125 | 3 |
| , MD | Pediatric Hematology-Oncology | Memphis, TN | $4,453 | 4 |
| , M.D | Pediatric Hematology-Oncology | Minneapolis, MN | $962.50 | 1 |
| , M.D | Pediatric Hematology-Oncology | Dallas, TX | $792.96 | 2 |
| , M.D | Medical Oncology | Baltimore, MD | $550.00 | 1 |
| , MD | Pediatric Hematology-Oncology | Miami, FL | $550.00 | 1 |
| , M.D, PHD | Internal Medicine | Houston, TX | $500.00 | 1 |
| , MD | Pediatrics | Philadelphia, PA | $125.18 | 1 |
| Stacy Cooper | Pediatric Hematology-Oncology | Baltimore, MD | $125.18 | 1 |
| , M.D | Pediatric Hematology-Oncology | Chicago, IL | $125.18 | 1 |
| , D.O | Pediatric Hematology-Oncology | Salt Lake City, UT | $125.18 | 1 |
| , M.D | Pediatrics | Philadelphia, PA | $125.18 | 1 |
| , MD | Pediatric Hematology-Oncology | Aurora, CO | $125.18 | 1 |
| , M.D | Pediatric Hematology-Oncology | Kansas City, MO | $125.18 | 1 |
| , M.D | Pediatric Hematology-Oncology | Cincinnati, OH | $125.18 | 1 |
| , M.D | Internal Medicine | Los Angeles, CA | $125.18 | 1 |
| , MD | Nephrology | Evanston, IL | $124.16 | 1 |
| , MD | Pediatric Hematology-Oncology | Winfield, IL | $124.16 | 1 |
| , MD | Pediatric Hematology-Oncology | Nashville, TN | $77.03 | 1 |
| , MD | Pediatrics | Orange, CA | $39.01 | 1 |
| , M.D | Pediatric Hematology-Oncology | Orange, CA | $39.01 | 1 |
| , MD | Pediatric Hematology-Oncology | Madera, CA | $33.16 | 1 |
| , M.D | Pediatrics | Sioux Falls, SD | $23.88 | 1 |
| , MD | Pulmonary Disease | Alabaster, AL | $23.16 | 1 |
Ad
Manufacturing Companies
- Jazz Pharmaceuticals Inc. $84,303
- JAZZ PHARMACEUTICALS INC. $10,037
Product Information
- Type Drug
- Total Payments $94,340
- Total Doctors 68
- Transactions 75
About ERWINAZE
ERWINAZE is a drug associated with $94,340 in payments to 68 healthcare providers, recorded across 75 transactions in the CMS Open Payments database. The primary manufacturer is Jazz Pharmaceuticals Inc..
Payment data is available from 2019 to 2024. In 2024, $42.40 was paid across 2 transactions to 2 doctors.
The most common payment nature for ERWINAZE is "Grant" ($75,000, 79.5% of total).